The pulsed dye laser: its use at 577 nm wavelength.
The ability to increase laser-induced cutaneous blood vessel damage selectivity is dependent upon optimizing various intrinsic laser parameters. Varying the laser emission wavelength, pulse duration, and/or incident energy dosage allows the clinician potential improvement in the laser treatment of cutaneous small blood vessel processes such as port-wine hemangioma and telangiectasia. The pulsed dye laser at 577 nm and a pulse duration of 300 to 400 microseconds, incorporates desired laser parameters into its design. Clinical evaluation of the therapeutic outcome with this laser reveals favorable results while significantly minimizing potential adverse side effects.
D006391:Hemangioma / Q000601:surgery; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D012867:Skin / Q000098:blood supply*; D012871:Skin Diseases / Q000601:surgery*; D012878:Skin Neoplasms / Q000601:surgery; D013684:Telangiectasis / Q000601:surgery